-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the evening of April 18, Puli Pharmaceuticals (300630.
Levofloxacin (levofloxacin, LVLX) is the levofloxacin optical isomer of the fluoroquinolone drug ofloxacin, and its antibacterial activity in vitro is twice that of ofloxacin.
Zhejiang Puli's levofloxacin tablets have been submitted for registration in the European Union (Netherlands and Germany) and China after the start of research and development.